Michel Burnier

Treasurer at European Society of Hypertension

Michel Burnier

Michel Burnier

Treasurer at European Society of Hypertension

Overview
Career Highlights

Speedel Pharma AG
Swiss Society of Hypertension
Swiss Society of Nephrology

RelSci Relationships

123

Number of Boards

5

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Michel Burnier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman & President at Neue Zürcher Zeitung AG

Relationship likelihood: Strong

Co-Founder at EIP Pharma, Inc.

Relationship likelihood: Strong

Director & Head-Investor Relations at Vifor Pharma AG

Relationship likelihood: Strong

Professional at Galenica AG

Relationship likelihood: Strong

Chief Executive Officer, Vifor Pharma at Vifor Pharma AG

Relationship likelihood: Strong

Former General Counsel & Member of the Executive Board at Credit Suisse Group AG

Relationship likelihood: Strong

Former Group General Counsel at Nestlé SA

Relationship likelihood: Strong

Secretary & Director at Vifor Pharma AG

Relationship likelihood: Strong

Chief Executive Officer, Galenica Santé at Vifor Pharma AG

Relationship likelihood: Strong

Chief Executive Officer at Corvidia Therapeutics, Inc.

Relationship likelihood: Strong

In The News
Paths to Michel Burnier
Potential Connections via
Relationship Science
You
Michel Burnier
Treasurer at European Society of Hypertension
Education

The University of Lausanne is a higher teaching and research institution composed of seven faculties where approximately 14,300 students and 3,000 researchers work and study. UNIL is focused on several academic disciplines, especially Medicine, Life Sciences, Geosciences, Environment, Business, Humanities and Social Sciences. An emphasis is placed on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors.

Memberships
Career History
Deputy Chairman-Executive Board
Current

Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland.

Boards & Committees
Director
2017 - Current

Galenica AG provides health, beauty, and wellbeing products and services. It operates through Health & Beauty, and Services segments. The Health & Beauty segment comprises the business sectors Products & Brands and Retail, which together with the pharmacy network in Switzerland. The Services segment comprises the logistics companies and HCI Solutions, which support players in the Swiss healthcare market with solutions from a single source. The company was founded on February 13, 2017 and is headquartered in Bern, Switzerland.

Non-Executive Director
2010 - Current

Vifor Pharma AG, formerly Galenica AG, is a global pharmaceuticals company, which engages in the research, development, production, and marketing of pharmaceutical products in iron deficiency, nephrology, and cardio-renal therapies. The company is the partner of choice for specialty pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures, and markets pharmaceutical products for precision patient care. The Group consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma, a joint company with Fresenius Medical Care; Relypsa; and OM Pharma. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Director
Current

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. The firm also offers a diversified portfolio of prescription medicines as well as over-the-counter products. It operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription (OTC, overthe-counter) products. The company was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michel Burnier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michel Burnier's profile does not indicate a business or promotional relationship of any kind between RelSci and Michel Burnier.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/michel-burnier-3716913
  • https://relationshipscience.com/person/michel-burnier-3716913